Facebook
X
LinkedIn
ForwardHematology & Medical Oncology Practice Updates and Board Review 2026
This course offers Live (in-person) and Livestream (virtual) attendance options
Course Director: Kebede H. Begna, M.D.
Co-Directors: Tanios S. Bekaii-Saab, M.D., Naseema Gangat, M.B.B.S., Wilson I. Gonsalves, M.D., Thor R. Halfdanarson, M.D., Rami Manochakian, M.D., Sameer A. Parikh, M.B.B.S., and Kathryn J. Ruddy, M.D.
February 6 - 10, 2026 - Grand Hyatt Kauai Resort & Spa - Koloa, Hawaii
The Mayo Clinic Hematology & Medical Oncology Practice Updates and Board Review course is designed to provide attendees with up-to-date, practical information and best practices that can be applied immediately into daily clinical practice. In addition, the high-yield program content prepares candidates for the American Board of Internal Medicine (ABIM) initial and maintenance of certification examinations in hematology and medical oncology.
Course Highlights:
- Comprehensive, high-yield review led by Mayo Clinic experts
- Updates on latest guidelines and practices in the field
- Dedicated time for questions and discussion
- Daily optional practice sessions in board review format
- Access to course recordings for one year
To see the course fee, please log in or create an account
| Registration Fee(s) | |
|---|---|
| M.D., D.O., Ph.D. | $1450 |
| Allied Health, NP, PA, Retirees | $1250 |
| Residents, Fellows | $775 |
Target Audience
This course is designed for hematologists, oncologists, internal medicine physicians, NPs, PAs and other internists with interest in hematology and medical oncology. Others that may find this course beneficial include physicians needing MOC and those preparing for certification or recertification in hematology and medical oncology.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Choose appropriate molecular tests like next generation sequencing for cancer diagnosis.
- Integrate into practice the most current treatment options like immuno- or targeted therapy for cancers.
- Utilize evidence-based practice to manage patients with bleeding and/or clotting disorders.
- Manage and mitigate important acute and long-term toxicities to treatment.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Friday, February 6 | |
5:45 AM | Registration, Breakfast, Exhibitors |
6:25 AM | Welcome Announcements |
Myeloid Neoplasms | |
6:30 AM | MPN: PV, ET, and MF |
7:00 AM | Mast Cell& Eosinophilic Neoplasms |
7:20 AM | Bone marrow failure syndromes (AA and CCUS/ICUS) including CMML and MDS |
7:50 AM | CML |
8:10 AM | Acute Myeloid Leukemia |
8:40 AM | Acute Lymphoblastic Leukemia |
9:10 AM | Transplantation (auto & Allo) for Hematological Disorders including GVHD |
9:40 AM | Panel Question & Answer Session |
10:00 AM | Refreshment Break & Exhibitors |
Consultative & Classic Hematology | |
10:10 AM | Thrombotic Microangiopathy and other Platelet Disorders |
10:35 AM | Coagulation Factors Disorder (Homeostasis): Molecular Basis, Inherited and Acquired Bleeding Disorders (non-Platlet) |
11:00 AM | Hemophagocytic Lymphositiocytosis (HLH) & Porphyrias |
11:20 AM | Sickel Cell Disease, Thalassemia & Other Hemoglobinopathies |
11:45AM | Anemia / Iron Metabolism Disorders |
12:10 PM | Hemolytic Anemias including PNH |
12:35 PM | Panel Question & Answer Session |
12:50 PM | Adjourn |
12:55 PM | Optional Industry Sponsored Lunch
Syndax |
Saturday, February 7 | |
5:45 AM | Registration, Breakfast, Exhibitors |
6:25 AM | Welcome Announcements |
Plasma Cell Disorders | |
6:30 AM | MGUS / Smoldering Myeloma |
6:50 AM | Waldenstrom Macroglobulinemia |
7:05 AM | Amyloidosis |
7:25 AM | Panel Question and Answer Session |
7:35 AM | Newly Diagnosed Multiple Myeloma |
7:55 AM | Relapsed / Refractory Multiple Myeloma |
8:15 AM | Cellular Therapy for Hematological Malignancies |
8:35 AM | Panel Question and Answer Session |
8:45 AM | Refreshment Break & Exhibitors |
Lymphoid Malignancies | |
9:05 AM | Hodgkin Lymphoma |
9:25 AM | Aggressive B Cell Lymphoma |
9:55 AM | T-Cell Lymphoma |
10:15 AM | Panel Question and Answer Session |
10:30 AM | CLL |
10:55 AM | Follicular Lymphoma |
11:15 AM | Mantle Cell Lymphoma |
11:30 AM | Other Indolent Non-Hodgkin Lymphoma |
11:45 AM | Panel Question and Answer Session |
12:00 PM | Adjourn |
12:05 PM | Optional Industry Sponsored Lunch – 45 minutes |
4:45 PM – 6:30 PM | Attendee Networking Reception |
Sunday, February 8 | |
5:45 AM | Registration, Breakfast, Exhibitors |
6:25 AM | Welcome Announcements |
Gynecologic and Other Cancers | |
6:30 AM | Ovarian Cancer |
7:00 AM | Cancers of the Cervix, Uterus and Other Less Common GYN Cancers |
7:30AM | Melanoma |
8:00 AM | Endocrine Oncology |
8:30 AM | Panel Question and Answer Session |
8:50 AM | Refreshment Break & Exhibitors |
Miscellaneous | |
9:05 AM | Genomics for Hematologist/Medical Oncologist |
9:30 AM | Hereditary Syndromes |
9:55 AM | Transfusion Medicine for Hematologist/Medical Oncologist |
10:20 AM | Panel Question and Answer Session |
10:40 AM | Refreshment Break & Exhibitors |
10:55 AM | Management of Thrombosis in Cancer |
11:25 AM | Palliative Care and Symptom Management |
11:55 AM | Assessing/Managing Complications of Therapy |
12:15 PM | Panel Question and Answer Session |
12:25 PM | Adjourn |
12:30 PM | Optional Industry Sponsored Lunch – 45 minutes |
Monday, February 9 | |
5:45 AM | Registration, Breakfast, Exhibitors |
6:25 AM | Welcome Announcements Thor R. Halfdanarson M.D. and Rami Manochakian, M.D. |
Lung, other Thoracic, Head & Neck Cancer, Neuro-Oncology | |
6:30 AM | Early-Stage NSCLC |
6:55 AM | Advanced Stage NSCLC |
7:40 AM | Small Cell Lung Cancer |
8:05 AM | Other Thoracic Malignancies |
8:25 AM | Panel Question and Answer Session |
8:45 AM | Refreshment Break & Exhibitors |
9:00 AM | Neuro-Oncology |
9:30AM | Head and Neck Cancer |
9:55AM | Sarcoma |
10:15 AM | Panel Question and Answer Session |
10:35 AM | Refreshment Break & Exhibitors |
Genitourinary Cancer | |
10:50 AM | Bladder / Urothelial Cancer |
11:20AM | Renal Cell Carcinoma |
11:50 AM | Germ Cell Cancers |
12:10PM | Prostate Cancer |
12:40PM | Panel Question and Answer Session |
1:00PM | Adjourn |
1:05 PM | Optional Industry Sponsored Lunch
Johnson & Johnson |
Tuesday, February 10 | |
5:45 AM | Registration, Breakfast, Exhibitors |
6:55 AM | Welcome Announcements |
Breast Cancer | |
6:30 AM | Early Breast Cancer – Locoregional Therapy |
6:50 AM | Systemic Therapy for ER+Her2- Breast Cancer: Curative & Palliative |
7:15 AM | Systemic Therapy for Triple Negative Breast Cancer: Curative & Palliative |
7:50 AM | Systemic Therapy for Her2- Positive Breast Cancer: Curative & Palliative |
8:25AM | Panel Question and Answer Session |
8:45 AM | Refreshment Break & Exhibitors |
Gastrointestinal Cancer | |
9:00 AM | Management of Early-stage Colorectal Cancer Including Non-Operative Management of Rectal Cancer |
9:30 AM | Management of Advanced Colorectal Cancer |
10:00 AM | Upper GI & other GI Cancers |
10:30 AM | Management of Hepatobiliary Cancers |
11:00 AM | Management of Pancreatic Cancer |
11:30 AM | Panel Question and Answer Session |
11:50 AM | Adjourn |
The room block at the Grand Hyatt Kauai is currently sold out. You may check the link below periodically for any cancellations. Additionally, we are working to secure an overflow room block at a nearby hotel, which we anticipate will be available within the next few weeks.
Notify me when rooms are available for Hematology & Medical Oncology Practice Updates and Board Review 2026 The Grand Hyatt Kauai Resort & Spa has reserved a limited block of guest rooms at a special group rate ranging from $409.00 – $509.00/night (USD) plus a daily resort fee of $15.00 and all applicable taxes. Group rates apply three days prior to and three days after the course dates, based on group room availability. To ensure accommodation at the discounted rate, make your reservations directly with the hotel before the block is full or by January 4, 2026, whichever comes first.
Reservations can be made directly in the room block online or by phone, 1-800-233-1234 – make sure to reference group “Mayo Clinic Hematology/Oncology 2026” if making your reservation by phone.
A deposit may be required to secure your reservation. Please contact the hotel directly with any questions.
Travel
All travel and lodging expenses are the sole responsibility of the individual registrant. Mayo Clinic School of Continuous Professional Development is not responsible for expenses incurred by an individual who is not confirmed and for whom space is not available at the meeting. Costs incurred by the registration such as airline or hotel fees or penalties are the responsibility of the registrant.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this other activity (live, livestream, and online content) for a maximum of 27.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Internal Medicine (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 27.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Other Healthcare Professionals:
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
| Day | Credit(s) |
|---|---|
| Friday | 6.00 |
| Saturday | 5.00 |
| Sunday | 5.50 |
| Monday | 5.75 |
| Tuesday | 5.00 |
| Total | 27.25 |
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 27.25 ABIM
- 27.25 ABS
- 27.25 AMA PRA Category 1 Credit™
- 27.25 Attendance
This course offers the unique opportunity for commercial companies to interact with healthcare providers and highlight their products and services. Please see the following information if you are interested in exhibiting at or sponsoring this course:
Sponsorship Prospectus *As of 09/17/2025, all of the following are fulfilled:
- All Product Theatres
- Platinum Sponsorship
- Gold Sponsorship
- Silver Sponsorship
- Exhibit Tables
Submit information/requests to Jessica Sorensen
To see the course fee, please log in or create an account
| Registration Fee(s) | |
|---|---|
| M.D., D.O., Ph.D. | $1450 |
| Allied Health, NP, PA, Retirees | $1250 |
| Residents, Fellows | $775 |
Please update your profile to let us know if you have dietary restrictions or access requirements.
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Belonging and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which all individuals are valued, allowing all to achieve their fullest potential.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.